Rupee rebounds 48 paise to close at 73.80 on RBI's assurance to maintain sufficient liquidity in currency market

Rebounding from its record low of 74.50, the rupee traded higher by 48 paise at 73.80 against the US currency on Friday after the Reserve Bank's assurance that steps will be taken to maintain sufficient liquidity in the panick-stricken currency market

Press Trust of India March 13, 2020 18:06:39 IST
Rupee rebounds 48 paise to close at 73.80 on RBI's assurance to maintain sufficient liquidity in currency market

Mumbai: Rebounding from its record low of 74.50, the rupee traded higher by 48 paise at 73.80 against the US currency on Friday after the Reserve Bank's assurance that steps will be taken to maintain sufficient liquidity in the panick-stricken currency market.

At the interbank foreign exchange, the rupee opened lower at 74.39 and slid further to the day's low of 74.50 against the US dollar as investors panicked weighing turmoil in financial markets due to coronavirus fears.

But, the domestic unit recovered sharply to 73.80, up 48 paise against the US dollar, buoyed by measures by the central bank to arrest the rupee free-fall.

In the current month so far, FPIs have pulled out a whopping Rs 37,954 crore ($5.14 billion) from Indian capital markets.

Rupee rebounds 48 paise to close at 7380 on RBIs assurance to maintain sufficient liquidity in currency market

Representational image. Reuters.

Foreign investors remained net sellers in Indian capital markets for a fifth straight day, pulling out more than Rs 4,700 crore on Friday amid a global sell-off in equities, market data showed.

The benchmark 10-year Indian government bond yield was higher at 6.32 percent.

Meanwhile, the global crude oil benchmark Brent Futures surged nearly 6 percent to trade at $35.11 per barrel.

The dollar index, which gauges the greenback's strength against a basket of six currencies, rose 0.44 percent to 97.90.

The RBI has said it is closely monitoring the current global situation and assured that it will take all steps to keep markets adequately liquid and stable.

"The RBI is closely and continuously monitoring the rapidly evolving global situation and will take all necessary measures to ensure that money, debt and forex markets remain adequately liquid and stable, and continue to function normally," the central bank said in a statement.

The RBI earlier also announced measures to infuse liquidity in the foreign exchange market, including the US dollar swaps worth $2 billion.

On the equity front, recovering over 5,380 points from its intra-day low of 29,388.97, the BSE Sensex ended 1,325.34 points or 4.04 percent higher at 34,103.48.

Similarly, the NSE Nifty settled 365.05 points, or 3.81 percent, up at 9,955.20.

As coronavirus-led recession fears triggered panic selling globally, indices plunged over 10 percent in the opening session, hitting their lower circuit levels.

Stock exchanges halted trading for 45 minutes within 15 minutes of market opening. Normal trading resumed at around 1030 hours.

Updated Date:

also read

What is camel flu, a virus deadlier than COVID, that could strike Qatar amid FIFA World Cup 2022?
Health

What is camel flu, a virus deadlier than COVID, that could strike Qatar amid FIFA World Cup 2022?

As 1.2 million football enthusiasts gather in Qatar for the FIFA World Cup 2022, the WHO has warned of a possible outbreak of camel flu, also known as the Middle East Respiratory System (MERS). Considered to be a deadlier cousin of COVID-19, it kills up to a third of those who get infected

Acquisition of Citibank India may get postponed till May: Axis Bank MD
Business

Acquisition of Citibank India may get postponed till May: Axis Bank MD

After the merger is complete, Axis Bank will have approximately 10.6 million active cards and 28.5 million active savings accounts

Bharat Biotech’s Intranasal COVID-19 vaccine gets CDSCO approval
Health

Bharat Biotech’s Intranasal COVID-19 vaccine gets CDSCO approval

iNCOVACC is the world’s first Intranasal vaccine for COVID to receive approval for the primary 2-dose schedule, and heterologous booster dose